Scandion Oncology (Sweden) Alpha and Beta Analysis
| SCOL Stock | SEK 0 0 38.81% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Scandion Oncology AS. It also helps investors analyze the systematic and unsystematic risks associated with investing in Scandion Oncology over a specified time horizon. Remember, high Scandion Oncology's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Scandion Oncology's market risk premium analysis include:
Beta 0.17 | Alpha (0.34) | Risk 14.52 | Sharpe Ratio (0.08) | Expected Return (1.22) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Scandion |
Scandion Oncology Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Scandion Oncology market risk premium is the additional return an investor will receive from holding Scandion Oncology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Scandion Oncology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Scandion Oncology's performance over market.| α | -0.34 | β | 0.17 |
Scandion Oncology Fundamentals Vs Peers
Comparing Scandion Oncology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Scandion Oncology's direct or indirect competition across all of the common fundamentals between Scandion Oncology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Scandion Oncology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Scandion Oncology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Scandion Oncology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Scandion Oncology to competition |
| Fundamentals | Scandion Oncology | Peer Average |
| Return On Equity | -0.74 | -0.31 |
| Return On Asset | -0.42 | -0.14 |
| Operating Margin | 473.28 % | (5.51) % |
| Current Valuation | (6.85 M) | 16.62 B |
| Shares Outstanding | 40.71 M | 571.82 M |
| Shares Owned By Insiders | 1.82 % | 10.09 % |
| Price To Book | 1.01 X | 9.51 X |
Scandion Oncology Opportunities
Scandion Oncology Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Scandion Oncology Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Scandion or other stocks. Alpha measures the amount that position in Scandion Oncology has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Scandion Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Scandion Oncology's short interest history, or implied volatility extrapolated from Scandion Oncology options trading.
Build Portfolio with Scandion Oncology
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Scandion Stock Analysis
When running Scandion Oncology's price analysis, check to measure Scandion Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scandion Oncology is operating at the current time. Most of Scandion Oncology's value examination focuses on studying past and present price action to predict the probability of Scandion Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scandion Oncology's price. Additionally, you may evaluate how the addition of Scandion Oncology to your portfolios can decrease your overall portfolio volatility.